Medicinova (MNOV) Net Cash Flow (2010 - 2025)
Medicinova (MNOV) posted quarterly Net Cash Flow of -$2.0 million for Q4 2025, down 4.4% year-over-year from -$2.1 million in Q4 2024, and down 18.41% quarter-over-quarter from -$1.7 million in Q3 2025.
Medicinova (MNOV) Net Cash Flow (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has reported Net Cash Flow for 16 consecutive years, with -$2.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Net Cash Flow fell 4.4% year-over-year to -$2.0 million; the TTM figure through Dec 2025 stood at -$9.8 million (up 7.82% YoY), while the FY2025 annual figure was -$9.6 million, up 10.1% from the prior year.
- Net Cash Flow retreated to -$2.0 million in Q4 2025 per MNOV's latest filing, from -$1.7 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $36.8 million in Q1 2023 and bottomed at -$34.0 million in Q4 2022.
- Historically, Net Cash Flow has averaged -$974964.4 across 5 years, with a median of -$2.4 million in 2023.
- Annual changes were most pronounced in 2022 — Net Cash Flow slumped 844.71% — and 2023, when it jumped 1085.72%.
- Medicinova's Net Cash Flow stood at -$3.6 million in 2021, then plunged by 844.71% to -$34.0 million in 2022, then jumped by 98.53% to -$499038.0 in 2023, then slumped by 287.09% to -$1.9 million in 2024, then decreased by 4.4% to -$2.0 million in 2025.
- Business Quant data shows MNOV's Net Cash Flow at -$2.0 million in Q4 2025, -$1.7 million in Q3 2025, and -$2.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.02 Mn |
| Dec 31, 2025 | -2.02 Mn |
| Sep 30, 2025 | -1.70 Mn |
| Sep 30, 2025 | -1.70 Mn |
| Jun 30, 2025 | -2.31 Mn |
| Jun 30, 2025 | -2.31 Mn |
| Mar 31, 2025 | -3.78 Mn |
| Mar 31, 2025 | -3.78 Mn |
| Dec 31, 2024 | -1.93 Mn |
| Dec 31, 2024 | -1.93 Mn |
| Sep 30, 2024 | -2.03 Mn |
| Sep 30, 2024 | -2.03 Mn |
| Jun 30, 2024 | -2.81 Mn |
| Jun 30, 2024 | -2.81 Mn |
| Mar 31, 2024 | -3.87 Mn |
| Mar 31, 2024 | -3.87 Mn |
| Dec 31, 2023 | -499,038.00 |
| Dec 31, 2023 | -499,038.00 |
| Sep 30, 2023 | -1.37 Mn |
| Sep 30, 2023 | -1.37 Mn |